Lin Cao
Fortuna: 773 M $ al 31/05/2026
Fortuna: 773 M $ al 31/05/2026
Lin Cao is currently the Chairman & General Manager at Nanjing Vazyme Biotech Co., Ltd. Dr. Cao has a graduate degree from Nanjing University, a doctorate degree from Nanjing University, an MBA from China Europe International Business School, and an undergraduate degree from Nanjing Agricultural University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2025 | 273.628.360 ( 68,8 % ) | 773 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NANJING VAZYME BIOTECH CO., LTD | Director Ejecutivo | 01/03/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Nanjing University
Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Europe International Business School
China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing Agricultural University
Nanjing Agricultural University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing Vazyme Biotech Co., Ltd.
Nanjing Vazyme Biotech Co., Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops enzymes, antigens, antibodies and polymer organic materials | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.